CASP3 and metabolic dysfunction-associated steatohepatitis: We found that VTE treatment prevented extensive apoptosis and increased gene expressions of cle-CASP3 and CHOP in mouse livers with MCDD-induced NASH, suggesting the VTE’s protective effects against hepatic death and ER stress in NASH.